Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice

被引:138
作者
Cao, J
Venton, L
Sakata, T
Halloran, BP
机构
[1] Vet Adm Med Ctr, Div Endocrinol, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
RANKL; osteoprotegerin; aging; bone; osteoblasts;
D O I
10.1359/jbmr.2003.18.2.270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoblasts regulate the recruitment and activity of osteoclasts through expression of RANKL and osteoprotegerin (OPG). To determine whether expression of RANKL and OPG change with age and how these changes relate to the bone loss of aging, we measured bone mass and cancellous volume, and expression of RANKL, OPG, alkaline phosphatase (AP), osteocalcin (OC), and alpha I collagen (COLL) in whole bone and osteoblast-like cells in culture using 6-week- (young), 6-month- (adult), and 24-month-old (old) mice. Cancellous volume decreased by 20% from young to adult and by 52% from adult to old. RANKL mRNA levels in whole bone were 2.1-fold and 4.4-fold higher in adult and old mice, respectively, compared with young mice, whereas OPG mRNA levels decreased with age slightly. RANKL expression was negatively (r = -0.99) and OPG was positively (r = 0.92) correlated with cancellous bone volume. Expression of RANKL was higher and OPG lower in cells from older animals early in culture (day 7). With cell maturation, RANKL mRNA levels in cells from young and adult mice increased, whereas levels in cells from old animals decreased. By 21 and 28 days of culture, no differences were found in RANKL mRNA in osteoblast-like cells among different age groups. We conclude that expression of RANKL and OPG change with age in whole bone and in cultured osteoblast-like cells. These changes favor increased osteoclast over osteoblast activity, and may explain, in part, the imbalance in bone formation and resorption associated with aging.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 26 条
[1]   AGE-RELATED BONE LOSS IN LUMBAR VERTEBRAE OF CW-1 FEMALE MICE - A HISTOMORPHOMETRIC STUDY [J].
BARSHIRAMAYMON, B ;
COLEMAN, R ;
COHEN, A ;
STEINHAGENTHIESSEN, E ;
SILBERMANN, M .
CALCIFIED TISSUE INTERNATIONAL, 1989, 44 (01) :36-45
[2]   The skeletal structure of insulin-like growth factor I-deficient mice [J].
Bikle, D ;
Majumdar, S ;
Laib, A ;
Powell-Braxton, L ;
Rosen, C ;
Beamer, W ;
Nauman, E ;
Leary, C ;
Halloran, B .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (12) :2320-2329
[3]   The physiology of brain histamine [J].
Brown, RE ;
Stevens, DR ;
Haas, HL .
PROGRESS IN NEUROBIOLOGY, 2001, 63 (06) :637-672
[4]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[5]   The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts [J].
Burgess, TL ;
Qian, YX ;
Kaufman, S ;
Ring, BD ;
Van, G ;
Capparelli, C ;
Kelley, M ;
Hsu, HL ;
Boyle, WJ ;
Dunstan, CR ;
Hu, S ;
Lacey, DL .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :527-538
[6]   The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis [J].
Fazzalari, NL ;
Kuliwaba, JS ;
Atkins, GJ ;
Forwood, MR ;
Findlay, DM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (06) :1015-1027
[7]   The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated [J].
Gori, F ;
Hofbauer, LC ;
Dunstan, CR ;
Spelsberg, TC ;
Khosla, S ;
Riggs, BL .
ENDOCRINOLOGY, 2000, 141 (12) :4768-4776
[8]   Changes in bone structure and mass with advancing age in the male C57BL/6J mouse [J].
Halloran, BP ;
Ferguson, VL ;
Simske, SJ ;
Burghardt, A ;
Venton, LL ;
Majumdar, S .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (06) :1044-1050
[9]   Expression profiles of receptor activator of nuclear factor κB ligand, receptor activator of nuclear factor κB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones [J].
Ikeda, T ;
Utsuyama, M ;
Hirokawa, K .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (08) :1416-1425
[10]  
KLEEREKOPER M, 1998, METABOLIC BONE DIS, P387